Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Boston Scientific Just Took A 9% Header. Why Analysts Are Still Bullish.
Boston Scientific’s stock (BSX) plummeted 9% to a two-year low after mixed test results for its Watchman FLX device, which prevents strokes. Despite the significant drop, analysts remain bullish on the medical device company, indicating confidence in the product’s long-term potential or other aspects of the business. The Watchman FLX is a minimally invasive device designed to seal off the heart’s left atrial appendage, where most blood clots form.